Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)-Reference-Cited by-同舟云学术

Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)

Published:2021-05-18 Issue:17 Volume:16 Page:2686-2694
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Vesga Luis C.¹²³,Kronenberger Thales¹⁴,Tonduru Arun Kumar¹,Kita Diogo Henrique⁵⁶,Zattoni Ingrid Fatima⁵,Bernal Cristian Camilo³,Bohórquez Arnold R. Romero³,Mendez‐Sánchez Stelia Carolina²³,Ambudkar Suresh V.⁶,Valdameri Glaucio⁵,Poso Antti¹⁴^ORCID

Affiliation:

1. Faculty of Health Sciences University of Eastern Finland Kuopio 70211 Finland

2. Escuela de Química Universidad Industrial de Santander A. A. 678 Bucaramanga Colombia

3. Grupo de Investigación en Compuestos Orgánicos de Interés Medicinal CODEIM Universidad Industrial de Santander A. A. 678 Piedecuesta Colombia

4. Department of Medical Oncology and Pneumology Internal Medicine VIII University Hospital of Tübingen Otfried-Müller-Strasse 14 72076 Tübingen Germany

5. Laboratory of Cancer Drug Resistance Federal University of Paraná PR 80210-170 Curitiba Brazil

6. Laboratory of Cell Biology Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda Maryland USA

Funder

Opetushallitus

National Cancer Institute

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202100188

Reference62 articles.